Article information
Full text is only aviable in PDF
Bibliografia
[1.]
C.A. Lazar, D.A. Culver.
Treatment of sarcoidosis.
Semin Respir Crit Care Med, 31 (2010), pp. 501-518
[2.]
G. Keir, A.U. Wells.
Assessing Pulmonary Disease and Response to Therapy: Which Test?.
Semin Respir Crit Care Med, 31 (2010), pp. 501-518
[3.]
M.C. Iannuzzi, B.A. Rybicki, A.S. Teirstein.
Sarcoidosis.
N Engl J Med, 357 (2007), pp. 2153-2165
[4.]
H. Nunes, P. Soler, D. Valeyre.
Pulmonary Sarcoidosis.
Allergy, 60 (2005), pp. 565-582
[5.]
R.P. Baughman.
Tumor necrosis factor inhibition in treating sarcoidosis: the American experience.
Revista Portuguesa de Pneumonologia, 13 (2007), pp. S47-S50
[6.]
R.P. Baughman, M. Drent, M. Kavuru, et al.
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Am J Respir Crit Care Med, 174 (2006), pp. 795-802
[7.]
S.A. Antoniu.
Targeting the TNF-alpha pathway in sarcoidosis.
Expert Opin Ther Targets, 14 (2010), pp. 21-29
[8.]
R.P. Baughman, M. Drent, M. Kavuru, et al.
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Am J Respir Crit Care Med, 174 (2006), pp. 795-802
[9.]
M.D. Rossman, L.S. Newman, R.P. Baughman, et al.
A double-blind, randomized, placebo-controlled trial of infliximab in patients with active pulmonary sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis, 23 (2006), pp. 201-208
[10.]
J.P. Utz, A.H. Limper, S. Kalra, et al.
Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis.
Chest, 124 (2003), pp. 177-185
[11.]
J.L. Callejas-Rubio, N. Ortego-Centeno, L. Lopez-Perez, et al.
Treatment of therapy-resistant sarcoidosis with adalimumab.
Clin Rheumatol, 25 (2006), pp. 596-597
[12.]
M. Aguiar, N. Marçal, A.C. Mendes, et al.
A. Infliximab for treating Sarcoidosis patients, Portuguese Experience.
Revista Portuguesa de Pneumologia, 17 (2011), pp. 85-93
[13.]
J.D. Doty, J.E. Mazur, M.A. Judson.
Treatment of sarcoidosis with infliximab.
Chest, 127 (2005), pp. 1064-1071
[14.]
T. Rosen, C. Doherty.
Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
Dermatol Online J, 13 (2007), pp. 14
[15.]
J.R. Smith, R.D. Levinson, G.N. Holland, et al.
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
Arthritis Rheum, 45 (2001), pp. 252-257
[16.]
S. Girlanda, P. Mantegani, E. Baldissera, et al.
ELISPOT-IFN-gamma assay instead of tuberculin skin test for detecting latent Mycobacterium tuberculosis infection in rheumatic patients candidate to anti-TNF-alpha treatment.
Clin Rheumatol, 29 (2010), pp. 1135-1141
Copyright © 2011. Sociedade Portuguesa de Pneumologia
